Skip to main content
. 2024 Jul 17;16(14):2563. doi: 10.3390/cancers16142563

Table 2.

Study population characteristics.

Characteristic Overall (n = 929)
N (%)
Eligible (n = 302)
N (%)
Consented (n = 88)
N (%)
p *
Age at diagnosis 0.43
<18 10 (1%) 1 (<1%) 0 (0%)
18–44 216 (23%) 60 (20%) 20 (23%)
45–64 481 (52%) 184 (61%) 48 (54%)
≥65 222 (24%) 57 (19%) 20 (23%)
Age at recruitment 0.12
<18 0 (0%) 0 (0%) 0 (0%)
18–44 87 (9%) 19 (6%) 9 (10%)
45–64 357 (39%) 113 (38%) 28 (32%)
≥65 485 (52%) 170 (56%) 51 (58%)
Race 0.69
American Indian/Alaskan Native 2 (<1%) 1 (<1%) 0 (0%)
Native Hawaiian/Other Pacific Islander 1 (<1%) 0 (0%) 0 (0%)
Asian 34 (4%) 11 (4%) 3 (3%)
Black/African American 25 (3%) 14 (5%) 4 (5%)
White 764 (82%) 239 (79%) 75 (85%)
Multiple Races 32 (3%) 5 (2%) 0 (0%)
Other Race 20 (2%) 7 (2%) 1 (1%)
Unknown/Not Reported 51 (6%) 25 (8%) 5 (6%)
Hispanic/Latino 0.58
Yes 89 (10%) 29 (10%) 6 (7%)
No 821 (88%) 262 (87%) 79 (90%)
Unknown/Not Reported 19 (2%) 11 (3%) 3 (3%)
Stage at diagnosis <0.0001
0 2 (<1%) 0 (0%) 0 (0%)
1 374 (40%) 157 (52%) 59 (67%)
2 83 (9%) 37 (12%) 5 (6%)
3 190 (20%) 58 (19%) 13 (15%)
4 71 (8%) 11 (4%) 0 (0%)
Unknown/Unstaged 209 (23%) 39 (13%) 11 (12%)

* p-value comparing the characteristics between the eligible and consenting populations.